{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:37:54Z","timestamp":1790674674754,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.neulet.2008.10.023","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T04:12:55Z","timestamp":1224043975000},"page":"166-169","source":"Crossref","is-referenced-by-count":30,"title":["Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease"],"prefix":"10.1016","volume":"448","author":[{"given":"Stefano","family":"Patassini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Giamp\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca R.","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2008.10.023_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neulet.2006.01.057","article-title":"Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients","volume":"399","author":"Cova","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2008.10.023_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0404.2006.00695.x","article-title":"The role of pleiotropic effects of statins in dementia","volume":"185","author":"Crisby","year":"2006","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.neulet.2008.10.023_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.nbd.2006.09.006","article-title":"Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity","volume":"25","author":"DeMarch","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2008.10.023_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2006.10.004","article-title":"Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment","volume":"25","author":"Franke","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2008.10.023_bib5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease","volume":"19","author":"Fusco","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2008.10.023_bib6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","article-title":"Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain","volume":"18","author":"Fusco","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2008.10.023_bib7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2008.10.023_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1471-4159.2006.04375.x","article-title":"Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein","volume":"101","author":"Johnson-Anuna","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2008.10.023_bib9","first-page":"327","article-title":"Bcl-2\/Bax: a rheostat that regulates an anti-oxidant pathway and cell death","volume":"4","author":"Korsmeyer","year":"1993","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neulet.2008.10.023_bib10","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1212\/01.WNL.0000142963.90204.58","article-title":"Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study","volume":"63","author":"Li","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2008.10.023_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/01.wnl.0000277657.95487.1c","article-title":"Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2008.10.023_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.neuint.2005.01.004","article-title":"Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease","volume":"46","author":"Lindberg","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2008.10.023_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molbrainres.2004.10.033","article-title":"3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells","volume":"133","author":"Mandavilli","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neulet.2008.10.023_bib14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pharmthera.2006.09.003","article-title":"Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects","volume":"113","author":"Miida","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2008.10.023_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ceca.2004.02.015","article-title":"Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function","volume":"36","author":"Ouyang","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neulet.2008.10.023_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0165-5728(02)00400-9","article-title":"Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis","volume":"134","author":"Sharief","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2008.10.023_bib17","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","article-title":"Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation","volume":"16","author":"Valenza","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2008.10.023_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pneurobio.2006.09.005","article-title":"Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?","volume":"80","author":"Valenza","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neulet.2008.10.023_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington's disease","volume":"28","author":"Valenza","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2008.10.023_bib20","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2008.10.023_bib21","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1523\/JNEUROSCI.23-35-11104.2003","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity","volume":"23","author":"Zacco","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2008.10.023_bib22","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1046\/j.1471-4159.2003.02105.x","article-title":"Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease","volume":"87","author":"Zhang","year":"2003","journal-title":"J. Neurochem."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439400801389X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439400801389X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T13:33:22Z","timestamp":1557840802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030439400801389X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S030439400801389X"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2008.10.023","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}